Atorvastatin reduces proinflammmatory markers in hypercholeterolemic patients (2004)
Source: Atherosclerosis. Unidade: FM
Subjects: HIPERCOLESTEROLEMIA(TERAPIA), BIOMARCADORES, CITOCINAS (ANÁLISE), DOENÇAS CARDIOVASCULARES (PREVENÇÃO E CONTROLE)
ABNT
ASCER, Elia et al. Atorvastatin reduces proinflammmatory markers in hypercholeterolemic patients. Atherosclerosis, v. no 2004, n. 1, p. 161-166, 2004Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2004.07.003. Acesso em: 11 nov. 2024.APA
Ascer, E., Bertolami, M. C., Venturinelli, M. L., Buccheri, V., Souza, V., Nicolau, J. C., et al. (2004). Atorvastatin reduces proinflammmatory markers in hypercholeterolemic patients. Atherosclerosis, no 2004( 1), 161-166. doi:10.1016/j.atherosclerosis.2004.07.003NLM
Ascer E, Bertolami MC, Venturinelli ML, Buccheri V, Souza V, Nicolau JC, Ramires JA, Serrano Junior CV. Atorvastatin reduces proinflammmatory markers in hypercholeterolemic patients [Internet]. Atherosclerosis. 2004 ; no 2004( 1): 161-166.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.07.003Vancouver
Ascer E, Bertolami MC, Venturinelli ML, Buccheri V, Souza V, Nicolau JC, Ramires JA, Serrano Junior CV. Atorvastatin reduces proinflammmatory markers in hypercholeterolemic patients [Internet]. Atherosclerosis. 2004 ; no 2004( 1): 161-166.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2004.07.003